PL1663991T3 - Selektywna synteza CF3 – podstawionych pirymidyn - Google Patents

Selektywna synteza CF3 – podstawionych pirymidyn

Info

Publication number
PL1663991T3
PL1663991T3 PL04769170T PL04769170T PL1663991T3 PL 1663991 T3 PL1663991 T3 PL 1663991T3 PL 04769170 T PL04769170 T PL 04769170T PL 04769170 T PL04769170 T PL 04769170T PL 1663991 T3 PL1663991 T3 PL 1663991T3
Authority
PL
Poland
Prior art keywords
substituted pyrimidines
selective synthesis
selective
synthesis
pyrimidines
Prior art date
Application number
PL04769170T
Other languages
English (en)
Polish (pl)
Inventor
John Charles Kath
Daniel Tyler Richter
Michael Joseph Luzzio
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PL1663991T3 publication Critical patent/PL1663991T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
PL04769170T 2003-09-05 2004-08-24 Selektywna synteza CF3 – podstawionych pirymidyn PL1663991T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50073303P 2003-09-05 2003-09-05
EP04769170A EP1663991B1 (en) 2003-09-05 2004-08-24 Selective synthesis of cf3-substituted pyrimidines
PCT/IB2004/002744 WO2005023780A1 (en) 2003-09-05 2004-08-24 Selective synthesis of cf3-substituted pyrimidines

Publications (1)

Publication Number Publication Date
PL1663991T3 true PL1663991T3 (pl) 2007-04-30

Family

ID=34272990

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04769170T PL1663991T3 (pl) 2003-09-05 2004-08-24 Selektywna synteza CF3 – podstawionych pirymidyn

Country Status (24)

Country Link
US (1) US7122670B2 (pt)
EP (1) EP1663991B1 (pt)
JP (1) JP4842816B2 (pt)
KR (1) KR100694732B1 (pt)
CN (1) CN100465164C (pt)
AR (1) AR045557A1 (pt)
BR (1) BRPI0414059B8 (pt)
CA (1) CA2537373C (pt)
CO (1) CO5650237A2 (pt)
CY (1) CY1106370T1 (pt)
DE (1) DE602004004287T2 (pt)
DK (1) DK1663991T3 (pt)
ES (1) ES2276344T3 (pt)
HK (1) HK1091824A1 (pt)
IL (1) IL173363A (pt)
MX (1) MXPA06002552A (pt)
NO (1) NO334383B1 (pt)
NZ (1) NZ544969A (pt)
PL (1) PL1663991T3 (pt)
PT (1) PT1663991E (pt)
RU (1) RU2315759C2 (pt)
TW (1) TWI283667B (pt)
WO (1) WO2005023780A1 (pt)
ZA (1) ZA200600747B (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2338545T3 (es) * 2002-12-20 2010-05-10 Pfizer Products Inc. Derivados de pirimidina para el tratamiento del crecimiento celular anormal.
US20060205945A1 (en) * 2004-05-14 2006-09-14 Pfizer Inc Pyrimidine derivatives for the treatment of abnormal cell growth
JP4778717B2 (ja) * 2005-03-25 2011-09-21 富士フイルム株式会社 複素環式化合物の製造方法
DE102007010801A1 (de) 2007-03-02 2008-09-04 Bayer Cropscience Ag Diaminopyrimidine als Fungizide
CN101678215B (zh) 2007-04-18 2014-10-01 辉瑞产品公司 用于治疗异常细胞生长的磺酰胺衍生物
KR101294731B1 (ko) * 2007-06-04 2013-08-16 삼성디스플레이 주식회사 어레이 기판, 이를 갖는 표시패널 및 이의 제조방법
EP2268621A1 (en) 2008-03-20 2011-01-05 Boehringer Ingelheim International GmbH Regioselective preparation of substituted pyrimidines
UY31714A (es) * 2008-03-20 2009-11-10 Boehringer Ingelheim Int Preparación selectiva de pirimidinas sustituidas
DE102009006643A1 (de) 2009-01-29 2010-08-05 Saltigo Gmbh Herstellung von halogenierten N-heteroaromatischen Polyhalogenderivaten
TW201100441A (en) * 2009-06-01 2011-01-01 Osi Pharm Inc Amino pyrimidine anticancer compounds
US8729265B2 (en) 2009-08-14 2014-05-20 Boehringer Ingelheim International Gmbh Regioselective preparation of 2-amino-5-trifluoromethylpyrimidine derivatives
US8933227B2 (en) * 2009-08-14 2015-01-13 Boehringer Ingelheim International Gmbh Selective synthesis of functionalized pyrimidines
PL2646448T3 (pl) 2010-11-29 2017-12-29 OSI Pharmaceuticals, LLC Makrocykliczne inhibitory kinazy
US8546443B2 (en) 2010-12-21 2013-10-01 Boehringer Ingelheim International Gmbh Benzylic oxindole pyrimidines
ES2691673T3 (es) 2011-02-17 2018-11-28 Cancer Therapeutics Crc Pty Limited Inhibidores de Fak
DK2675794T3 (da) 2011-02-17 2019-05-06 Cancer Therapeutics Crc Pty Ltd Selektive fak-inhibitorer
WO2014126954A1 (en) 2013-02-13 2014-08-21 OSI Pharmaceuticals, LLC Regioselective synthesis of substituted pyrimidines
GB2538476B (en) * 2014-05-08 2019-03-20 Tosoh F Tech Inc 5-(Trifluoromethyl)pyrimidine derivatives and method for producing same
JP6391985B2 (ja) * 2014-05-16 2018-09-19 東ソー・ファインケム株式会社 ２−置換−４−（２，２，２−トリフルオロエトキシ）−５−（トリフルオロメチル）ピリミジン誘導体及びその製造方法
JP6391988B2 (ja) * 2014-05-21 2018-09-19 東ソー・ファインケム株式会社 ５−（トリフルオロメチル）ピリミジン誘導体の製造方法及び新規５−（トリフルオロメチル）ピリミジン誘導体
CN108440499A (zh) * 2018-03-22 2018-08-24 盐城师范学院 一种色瑞替尼及其关键中间体的制备方法
CN114213339B (zh) * 2021-12-20 2023-10-31 苏州康纯医药科技有限公司 一种表皮细胞生长因子受体突变抑制剂的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003030909A1 (en) * 2001-09-25 2003-04-17 Bayer Pharmaceuticals Corporation 2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer
UY27487A1 (es) * 2001-10-17 2003-05-30 Boehringer Ingelheim Pharma Derivados de pirimidina, medicamentos que contienen estos compuestos, su empleo y procedimiento para su preparación

Also Published As

Publication number Publication date
ES2276344T3 (es) 2007-06-16
KR20060030918A (ko) 2006-04-11
IL173363A (en) 2010-05-31
JP2007504211A (ja) 2007-03-01
RU2006106727A (ru) 2006-06-27
HK1091824A1 (en) 2007-01-26
CA2537373C (en) 2009-10-20
CY1106370T1 (el) 2011-10-12
PT1663991E (pt) 2007-02-28
CN1845906A (zh) 2006-10-11
BRPI0414059A (pt) 2006-10-24
BRPI0414059B1 (pt) 2018-11-06
AU2004270480A1 (en) 2005-03-17
NO334383B1 (no) 2014-02-24
RU2315759C2 (ru) 2008-01-27
DE602004004287T2 (de) 2007-06-21
US7122670B2 (en) 2006-10-17
KR100694732B1 (ko) 2007-03-14
TW200514773A (en) 2005-05-01
EP1663991A1 (en) 2006-06-07
WO2005023780A1 (en) 2005-03-17
JP4842816B2 (ja) 2011-12-21
MXPA06002552A (es) 2006-06-20
NO20061509L (no) 2006-04-03
DK1663991T3 (da) 2007-04-10
CN100465164C (zh) 2009-03-04
IL173363A0 (en) 2006-06-11
CO5650237A2 (es) 2006-06-30
NZ544969A (en) 2008-07-31
DE602004004287D1 (de) 2007-02-22
CA2537373A1 (en) 2005-03-17
TWI283667B (en) 2007-07-11
EP1663991B1 (en) 2007-01-10
US20050101620A1 (en) 2005-05-12
BRPI0414059B8 (pt) 2021-05-25
AR045557A1 (es) 2005-11-02
ZA200600747B (en) 2007-03-28

Similar Documents

Publication Publication Date Title
IL173363A0 (en) Selective synthesis of cf3-substituted pyrimidines
HK1173394A1 (zh) 二酮哌嗪的合成
AU2003213092A8 (en) Syntheses of quinazolinones
ZA200605348B (en) Solid forms of anti-EGFR-antibodies
EP1778618A4 (en) SYNTHESIS OF TRIETHYLENETETRAMINES
EP1546115A4 (en) SUBSTITUTED PYRIMIDINES
EP1711484A4 (en) SYNTHESIS OF CYANOIMINO-BENZOIMIDAZOLES
EP1639121A4 (en) SYNTHESIS OF BETA-L-2-DESOXYNUCLEOSIDES
AU2003262794A8 (en) Total synthesis of heparin
GB0321091D0 (en) Synthesis
HK1097850A1 (en) Improved synthesis of 2-substituted adenosines
HK1095834A1 (en) Improved synthesis of 2-substituted adenosines
EP1602809A4 (en) MOUNTING CONSTRUCTION FOR THERMOSTAT
SI1663991T1 (sl) Selektivna sinteza CF3-substituiranih pirimidinov
IL178184A0 (en) Synthesis of pyrrole-2-carbonitriles
EG24122A (en) Process for the synthesis of 3-cyano-6-alkoxy-7-nitro-4-quinolines
PL375437A1 (en) Synthesis of gatifloxacin
GB0329319D0 (en) Synthesis
GB2422833B (en) Zaleplon synthesis
AU2003217354A8 (en) Synthesis of sulfamidates
GB0328318D0 (en) Synthesis of spongosine
GB0328321D0 (en) Synthesis of 2-substituted adenosines
TW573941U (en) Improved structure of heat sink
TW562061U (en) Structure of shaping forms
TW553243U (en) Structure of clotheshanger